european medicines agency glp-1 vision loss recommendation november 2025 Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch Meeting highlights from the Pharmacovigilance

doi: 10.1210/endrev/bnaa010 36 DabravolskiSANikiforovNGEidAHNedosugovaLVStarodubovaAVPopkovaTVet al

The 6 mg dose fared better as the mean weight loss change was 4.3%, achieving a p-value of 0.077 versus placebo

Let them air dry completely

These data suggest that H4R plays a role in neutrophil movement and migration into the mucosa, where neutrophils elicit the most tissue damage in colitis

At Mansculpt the procedure is performed by an experienced medic to minimise the associated side effects and ensure the treatment is as safe as it is effective

ALS is characterized by the progressive loss of motor neurons, leading to muscle weakness and paralysis